Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002085458A3 Use of nk-1 receptor antagonists against benign prostatic hyperplasia
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056916A3 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002020090A9 Pharmaceutical compositions
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001074136A3 Telomerase inhibitor polynucleotides
10/30/2003US20030204206 Electrically responsive promoter system
10/30/2003US20030204089 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203964 Process for producing medicaments which comprise HMG CoA reductase inhibitors
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203958 Therapeutic inhibitor of vascular smooth muscle cells
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203938 Epothilone derivatives and their synthesis and use
10/30/2003US20030203936 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203929 Microtubule stabilizing compounds
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203924 Combination for treating susceptible tumor comprising (S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f) quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid and folic acid
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203920 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203907 Novel pyrazinone derivatives
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203860 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
10/30/2003US20030203859 A combination of a bis-aryl compound (such as fipronil) and an avermectin or milbemycin or derivative useful as parasitic agent
10/30/2003US20030203857 Remedies
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203849 Composition promoting lacrimal secretion
10/30/2003US20030203838 Compositions and methods for inhibiting angiogenesis
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203403 Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203049 Triterpene compositions and methods for use thereof
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030202997 Killing parasites with fatty ester and organosilicon compound
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202990 Diffusion of brain, blood barrier
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202969 Enhancing therapeutic effectiveness of nitric oxide inhalation
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003CA2483311A1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482928A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482591A1 Combination therapy for the treatment of cancer
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003CA2482249A1 Dry powder inhalant composition
10/30/2003CA2482147A1 Medicament for therapeutic treatment of vascular disease
10/30/2003CA2482035A1 Novel sodium channel blockers
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481934A1 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/30/2003CA2481088A1 Use of materials having zinc ionophoric behavior
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480451A1 New 2-substituted -1,3-thiazole compounds
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1564